Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical outcome and monitoring of minimal residual disease in patients with acute lymphoblastic leukemia expressing the MLL/ENL fusion gene.
Elia L, Grammatico S, Paoloni F, Vignetti M, Rago A, Cenfra N, Mecarocci S, Mancini M, Luciani M, Di Raimondo F, Cazzaniga G, Matarazzo M, Moleti ML, Santoro L, Gaidano G, Foà R, Mandelli F, Cimino G. Elia L, et al. Among authors: mecarocci s. Am J Hematol. 2011 Dec;86(12):993-7. doi: 10.1002/ajh.22161. Epub 2011 Sep 22. Am J Hematol. 2011. PMID: 21953510 Free article.
A highly specific q-RT-PCR assay to address the relevance of the JAK2WT and JAK2V617F expression levels and control genes in Ph-negative myeloproliferative neoplasms.
Fantasia F, Di Capua EN, Cenfra N, Pessina G, Mecarocci S, Rago A, Cotroneo E, Busanello A, Equitani F, Lo-Coco F, Nervi C, Cimino G. Fantasia F, et al. Among authors: mecarocci s. Ann Hematol. 2014 Apr;93(4):609-16. doi: 10.1007/s00277-013-1920-0. Epub 2013 Oct 31. Ann Hematol. 2014. PMID: 24173087 Free PMC article.
Genetic lesions disrupting calreticulin 3'-untranslated region in JAK2 mutation-negative polycythemia vera.
Quattrocchi A, Maiorca C, Billi M, Tomassini S, De Marinis E, Cenfra N, Equitani F, Gentile M, Ceccherelli A, Banella C, Mecarocci S, Scerpa MC, Pisanò S, Pacilli A, Di Cristofano C, Mancini M, Guglielmelli P, Vannucchi AM, Noguera N, Grignani F, Cimino G, Nervi C. Quattrocchi A, et al. Among authors: mecarocci s. Am J Hematol. 2020 Oct;95(10):E263-E267. doi: 10.1002/ajh.25911. Epub 2020 Jul 20. Am J Hematol. 2020. PMID: 32572989 Free article. No abstract available.
Prognostic factors associated with progression of smoldering multiple myeloma to symptomatic form.
Rago A, Grammatico S, Za T, Levi A, Mecarocci S, Siniscalchi A, De Rosa L, Felici S, Bongarzoni V, Piccioni AL, La Verde G, Pisani F, Franceschini L, Paviglianiti AL, Caravita T, Petrucci MT, De Stefano V, Cimino G; Multiple Myeloma GIMEMA-Latium Region Working Group. Rago A, et al. Among authors: mecarocci s. Cancer. 2012 Nov 15;118(22):5544-9. doi: 10.1002/cncr.27657. Epub 2012 Jul 11. Cancer. 2012. PMID: 22786730 Free article.
Hemoglobin levels and circulating blasts are two easily evaluable diagnostic parameters highly predictive of leukemic transformation in primary myelofibrosis.
Rago A, Latagliata R, Montanaro M, Montefusco E, Andriani A, Crescenzi SL, Mecarocci S, Spirito F, Spadea A, Recine U, Cicconi L, Avvisati G, Cedrone M, Breccia M, Porrini R, Villivà N, De Gregoris C, Alimena G, D'Arcangelo E, Guglielmelli P, Lo-Coco F, Vannucchi A, Cimino G. Rago A, et al. Among authors: mecarocci s. Leuk Res. 2015 Mar;39(3):314-7. doi: 10.1016/j.leukres.2015.01.001. Epub 2015 Jan 12. Leuk Res. 2015. PMID: 25636356
A retrospective study on 73 elderly patients (≥75years) with aggressive B-cell non Hodgkin lymphoma: clinical significance of treatment intensity and comprehensive geriatric assessment.
Marchesi F, Cenfra N, Altomare L, Dessanti ML, Mecarocci S, Cerchiara E, Rago A, D'Andrea M, Tomarchio V, Olimpieri OM, Tirindelli MC, Mengarelli A, Petti MC, Avvisati G, Cimino G. Marchesi F, et al. Among authors: mecarocci s. J Geriatr Oncol. 2013 Jul;4(3):242-8. doi: 10.1016/j.jgo.2013.04.003. Epub 2013 May 7. J Geriatr Oncol. 2013. PMID: 24070462
24 results